Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AUTORISERET FYSIOTERAPEUT GORM HANSEN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   2.3% 3.0% 33.6% 22.1% 26.5% 21.8% 20.8% 19.2%   Credit score (0-100)   67 59 1 4 2 4 4 7   Credit rating   BBB BBB C B B B B B   Credit limit (kDKK)   0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,108 2,973 8,994 10.4 -12.4 -12.4 0.0 0.0   EBITDA   1,852 1,149 6,755 9.8 -12.4 -12.4 0.0 0.0   EBIT   1,695 1,112 6,739 9.8 -12.4 -12.4 0.0 0.0   Pre-tax profit (PTP)   1,693.0 1,114.4 6,724.9 9.0 -11.7 -8.2 0.0 0.0   Net earnings   1,298.7 869.7 5,374.1 7.1 -11.7 -8.2 0.0 0.0   Pre-tax profit without non-rec. items   1,693 1,114 6,725 7.7 -11.7 -8.2 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Tangible assets total   11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   1,489 1,109 1,183 190 178 170 44.8 44.8   Interest-bearing liabilities   3.2 1.6 3.1 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,181 1,652 1,360 205 188 177 44.8 44.8   Net Debt   -1,735 -1,202 -1,336 -203 -101 -46.8 -44.8 -44.8     See the entire balance sheet 1000.0 Volume  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,108 2,973 8,994 10.4 -12.4 -12.4 0.0 0.0   Gross profit growth   3.9% -4.3% 202.5% -99.9% 0.0% 0.4% 0.0% 0.0%   Employees   3 3 3 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% -100.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,181 1,652 1,360 205 188 177 45 45   Balance sheet change%   6.6% -24.3% -17.7% -84.9% -8.1% -5.7% -74.7% 0.0%   Added value   1,694.7 1,112.3 6,739.0 9.8 -12.4 -12.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -276 -49 -16 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   54.5% 37.4% 74.9% 93.7% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   80.2% 58.3% 447.5% 1.6% -5.2% -4.3% 0.0% 0.0%   ROI %   117.5% 85.8% 587.0% 1.9% -5.6% -4.6% 0.0% 0.0%   ROE %   90.2% 67.0% 469.1% 1.0% -6.4% -4.7% 0.0% 0.0%   1000.0 Solidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Equity ratio %   68.3% 67.1% 87.0% 92.7% 94.7% 95.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -93.7% -104.6% -19.8% -2,077.9% 811.0% 378.7% 0.0% 0.0%   Gearing %   0.2% 0.1% 0.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   79.9% 104.9% 608.3% 336.3% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Quick Ratio   3.1 3.0 7.7 13.8 18.8 23.6 0.0 0.0   Current Ratio   3.1 3.0 7.7 13.8 18.8 23.6 0.0 0.0   Cash and cash equivalent   1,738.2 1,203.5 1,338.8 202.9 100.6 46.8 0.0 0.0   1000.0 Capital use efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,477.2 1,108.6 1,182.7 189.8 178.1 169.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   565 371 2,246 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   617 383 2,252 0 0 0 0 0   EBIT / employee   565 371 2,246 0 0 0 0 0   Net earnings / employee   433 290 1,791 0 0 0 0 0